IRIS
FORTUNATO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.589
AS - Asia 1.229
EU - Europa 786
SA - Sud America 321
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.535
SG - Singapore 572
IT - Italia 381
BR - Brasile 242
CN - Cina 206
VN - Vietnam 164
IN - India 102
DE - Germania 88
EE - Estonia 85
HK - Hong Kong 80
FI - Finlandia 48
AR - Argentina 45
GB - Regno Unito 35
NL - Olanda 26
CA - Canada 24
BD - Bangladesh 20
RU - Federazione Russa 20
MX - Messico 19
SE - Svezia 18
FR - Francia 17
ID - Indonesia 16
IQ - Iraq 15
ZA - Sudafrica 15
PK - Pakistan 11
AT - Austria 10
EC - Ecuador 10
ES - Italia 9
JP - Giappone 9
CZ - Repubblica Ceca 8
CO - Colombia 7
PL - Polonia 7
UA - Ucraina 6
TN - Tunisia 5
VE - Venezuela 5
CL - Cile 4
GR - Grecia 4
MA - Marocco 4
PE - Perù 4
SA - Arabia Saudita 4
TR - Turchia 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
PT - Portogallo 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
JM - Giamaica 2
LT - Lituania 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
QA - Qatar 1
RW - Ruanda 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.968
Salva come PNG Salva come JPEG
Città #
Dallas 408
San Jose 286
Singapore 264
Ashburn 154
Santa Clara 108
Hong Kong 78
Bengaluru 75
Chandler 66
Hefei 63
Munich 59
Ho Chi Minh City 56
Beijing 48
Hanoi 43
Milan 42
Rome 36
Turku 30
Chicago 25
Boardman 23
London 22
São Paulo 20
Lawrence 19
Princeton 19
Helsinki 18
Orem 14
New York 13
Los Angeles 12
Wilmington 12
Catanzaro 11
Brooklyn 10
Buffalo 10
Da Nang 10
Genoa 10
San Francisco 10
Secaucus 10
Reggio Calabria 9
Amsterdam 8
Chennai 8
Johannesburg 8
Mexico City 8
Mingora 7
Naples 7
Pasadena 7
Piacenza 7
San Nicola Manfredi 7
Warsaw 7
Bari 6
Boston 6
Dhaka 6
Montreal 6
Rimini 6
Rio de Janeiro 6
Settingiano 6
Stockholm 6
Atlanta 5
Brasília 5
Lamezia Terme 5
Olomouc 5
Paris 5
Seattle 5
Tokyo 5
Valmadrera 5
Assago 4
Aversa 4
Belo Horizonte 4
Biên Hòa 4
Cabo Frio 4
Can Tho 4
Carrara 4
Curitiba 4
Falerna 4
Frankfurt am Main 4
Guayaquil 4
Haiphong 4
Huế 4
Lima 4
Piscataway 4
Pune 4
Taranto 4
Toronto 4
Verona 4
Alessandria 3
Baghdad 3
Bogotá 3
Buenos Aires 3
Carney 3
Caxias do Sul 3
Como 3
Council Bluffs 3
Crotone 3
Elk Grove Village 3
Giugliano in Campania 3
Guangzhou 3
Hanover 3
Isidro Casanova 3
Istanbul 3
Joinville 3
Locri 3
Maceió 3
Madrid 3
Marano Marchesato 3
Totale 2.391
Salva come PNG Salva come JPEG
Nome #
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 147
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 140
Efficacy of rehabilitative techniques in reducing hemiplegic shoulder pain in stroke: systematic review and meta-analysis 100
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 91
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 89
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 78
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 76
Glucose transporter-1 deficiency syndrome with extreme phenotypic variability in a five-generation family carrying a novel SLC2A1 variant 76
Efficacy of Virtual Reality and Exergaming in Improving Balance in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis 73
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 71
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study 68
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 68
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 68
Pain Management and Rehabilitation for Central Sensitization in Temporomandibular Disorders: A Comprehensive Review 66
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia 65
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 65
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 64
Climate change and hyponatremia-related hospital admissions in people with focal epilepsy exposed to carbamazepine or its derivatives 62
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 62
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 61
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 60
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 59
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 59
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 57
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 57
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 56
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 55
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 55
Novel KCNQ2 Variants Related to a Variable Phenotypic Spectrum Ranging from Epilepsy with Auditory Features to Severe Developmental and Epileptic Encephalopathies 54
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 53
Neuromuscular Impairment of Knee Stabilizer Muscles in a COVID-19 Cluster of Female Volleyball Players: Which Role for Rehabilitation in the Post-COVID-19 Return-to-Play? 52
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 52
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 51
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 51
May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study 49
Orbito-frontal thinning together with a somatoform dissociation might be the fingerprint of PNES 49
Ultrasound-Guided Injections and Proprioceptive Neuromuscular Facilitation as Shoulder Rehabilitation for Multiple Sclerosis and Neuropathic Pain 48
Personality disorders in individuals with functional seizures: a systematic review 48
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study 48
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 48
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 47
Focal epilepsy with sensory seizures associated with arginine:glycine amidinotransferase deficiency: A clinical and advanced magnetic resonance imaging study 47
Epilepsy, Immunity and Neuropsychiatric Disorders 47
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures 47
Genome-wide association meta-analyses of drug-resistant epilepsy 46
Functional activity changes in memory and emotional systems of healthy subjects with déjà vu. 46
Temporomandibular disorders and neck pain in primary headache patients: a retrospective machine learning study 45
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 45
The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study 43
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis 43
Epileptic belly dancing: a video-polygraphic recording 43
Patterns of subregional cerebellar atrophy across epilepsy syndromes: An ENIGMA‐Epilepsy study 42
Neuropsychiatric profile in average intelligent individuals with coexisting epilepsy and psychogenic non-epileptic seizures 42
Neuroma of the Inferior Alveolar Nerve: A Treatable Mimic of Refractory Trigeminal Neuralgia 42
Two Novel Variants in the CHRNA2 and SCN2A Genes in Italian Patients with Febrile Seizures 42
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy 41
Focal neuromyotonia associated with a C9ORF72 expansion mutation 41
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication 41
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 40
Tremor as an intrinsic feature of juvenile myoclonic epilepsy 39
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences 38
Climate change and disorders of the nervous system 37
Epilepsy with generalized tonic–clonic seizures alone: Electroclinical features and prognostic patterns 37
Effects of intensive rehabilitation on functioning in patients with mild and moderate Charcot–Marie-Tooth disease: a real-practice retrospective study 36
Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes 34
Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease 34
PAK3 pathogenic variant associated with sleep-related hypermotor epilepsy in a family with parental mosaicism 34
null 33
Late-Onset Ictal Asystole and Falls Related to Severe Coronary Artery Stenosis: A Case Report 33
Babylonian knowledge about temporal lobe epilepsy: distinguishing mesial from lateral forms 32
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 29
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 29
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 28
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data 24
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 23
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 21
Effect of patient-related factors on brivaracetam efficacy and tolerability: results from a multicentric, retrospective study 18
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 17
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) 16
Response: Letter to the Editor – Climate, hyponatremia, and epilepsy: A critical signal demanding broader scrutiny 9
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case–control study 8
Totale 4.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 9 1 0
2021/202288 0 0 0 10 7 14 5 15 16 8 11 2
2022/2023241 44 24 20 40 18 20 2 14 22 7 19 11
2023/2024190 27 30 13 14 19 22 17 14 6 4 6 18
2024/2025979 53 21 23 78 80 122 72 43 77 103 103 204
2025/20262.555 139 207 502 468 250 113 253 127 322 174 0 0
Totale 4.090